 |
 |

Papillary Thyroid Carcinoma
Prognostic Index for Survival Including the Histological Variety
S. Ortiz Sebastian, MD;
J. M. Rodríguez Gonzalez, MD;
P. Parilla Paricio, MD;
J. Sola Perez, MD;
D. Pérez Flores, PhD;
A. Piñero Madrona, MD;
P. Ramirez Romero, MD;
F. J. Tebar, MD
Arch Surg. 2000;135:272-277.
Background Numerous prognostic factors have been studied for survival in patients with papillary thyroid carcinoma (PTC), although there are few multivariate studies that include the histological variety of PTC.
Hypothesis There are prognostic factors that influence survival in a series of patients with PTC, including the histological variety, and a new prognostic index (PI) for survival can be formulated by accounting for these factors.
Design A retrospective study.
Setting A university hospital department of surgery.
Patients Between January 1970 and December 1995, 200 patients undergoing surgery for PTC were observed (mean follow-up, 8 years).
Main Outcome Measures A univariate analysis was done for survival rates using the Kaplan-Meier estimation method. The possible prognostic factors were evaluated using a multivariate analysis according to the Cox model. We formulated a PI and defined 3 risk groups (low, medium, and high) for mortality.
Results Of the 200 patients, 175 (87.5%) are still alive. Of the 25 deaths, 19 (9.5%) were due to the tumor. The survival was 97.5% at 1 year, 92.8% at 5, 89.5% at 10, and 83.9% at 15 and 20 years. The prognostic factors obtained after the multivariate analysis were age, tumor size, extrathyroid spread, and histological variant of the PTC. The PI is calculated as follows: PI = (2 x size) +(6 x spread) + (2 x variant) + (3 x age). As for the risk groups, the low-risk group showed a mortality of 0%; the medium-risk group, 17.1%; and the high-risk group, 76.5%.
Conclusions The histological variety of PTC has prognostic value for survival in patients with PTC. As risk factors for PTC mortality, we consider an age of 50 years or older, a tumor larger than 4 cm, the existence of extrathyroid spread, and a certain histological subtype of PTC. With these risk factors, it is possible to formulate a PI and classify patients into low-, medium-, and high-risk groups for mortality.
From the Departments of Surgery (Drs Ortiz Sebastian, Rodríguez Gonzalez, Parilla Paricio, Piñero Madrona, and Ramirez Romero), Pathology (Dr Sola Perez), Statistics (Dr Pérez Flores), and Endocrinology (Dr Javier Tebar), Hospital Universitario Virgen de la Arrixaca (Murcia), Servicio de Cirugía General y Aparato Digestivo (I), El Palmar, Murcia, Spain.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(3):375-376.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Simplifying the TNM System for Clinical Use in Differentiated Thyroid Cancer
Onitilo et al.
JCO 2009;27:1872-1878.
ABSTRACT
| FULL TEXT
Thyroid Cancer in Adults
SCOTT
radtech 2009;80:241-261.
ABSTRACT
| FULL TEXT
Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
Lang et al.
Endocr Relat Cancer 2007;14:29-42.
ABSTRACT
| FULL TEXT
Follicular Variant of Papillary Thyroid Carcinoma: A Long-term Follow-up
Passler et al.
Arch Surg 2003;138:1362-1366.
ABSTRACT
| FULL TEXT
Surgical Treatment of Cervical Nodal Metastases in Patients With Papillary Thyroid Carcinoma
Bhattacharyya
Arch Otolaryngol Head Neck Surg 2003;129:1101-1104.
ABSTRACT
| FULL TEXT
|